论文信息 - Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column

Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column

A mixed-phase liquid chromatographic column was used to assay fluconazole in plasma, serum, and cerebrospinal fluid. The assay was linear from 0.2 to 20 micrograms/ml, with an average coefficient of variation of less than 5%. The partitioning of the drug between serum and cerebrospinal fluid was determined for 34 patients. The method was demonstrated to be suitable for both pharmacokinetic studies and monitoring of patients receiving treatment with this antifungal agent.

[1] I. Yoshiya,et al. Rapid determination of serum levels of a new antifungal agent, fluconazole, by high-performance liquid chromatography. , 1990, Journal of chromatography.

[2] H. Washton. Review of fluconazole: a new triazole antifungal agent. , 1989, Diagnostic microbiology and infectious disease.

[3] M. Rinaldi,et al. Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection , 1989, Antimicrobial Agents and Chemotherapy.

[4] D. Debruyne,et al. Determination of fluconazole in biological fluids by capillary column gas chromatography with a nitrogen detector. , 1988, Journal of pharmaceutical sciences.

[5] A. Catanzaro,et al. Fluconazole Penetration into Cerebrospinal Fluid in Humans , 1988, Journal of clinical pharmacology.

[6] F. Balis,et al. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. , 1988, The Journal of infectious diseases.

[7] M J Humphrey,et al. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.